Bristol-Myers Squibb Company (BMY)
NYSE · Healthcare
Bristol-Myers Squibb Company EPS 2007–2025
Bristol-Myers Squibb Company annual/quarterly eps history and growth rate from 2007 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Bristol-Myers Squibb Company eps for the quarter ending March 31, 2026 was $1.31, a 9.17% increase year-over-year.
- Bristol-Myers Squibb Company annual eps for 2025 was $3.46, a 178.46% decrease from 2024.
- Bristol-Myers Squibb Company annual eps for 2024 was $4.41, a 214.25% decrease from 2023.
- Bristol-Myers Squibb Company annual eps for 2023 was $3.86, a 30.85% increase from 2022.
- Bristol-Myers Squibb Company annual eps for 2022 was $2.95.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Bristol-Myers Squibb Company EPS — FAQ
Bristol-Myers Squibb Company (BMY) eps over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
What is Bristol-Myers Squibb Company's eps?
Bristol-Myers Squibb Company (BMY) reported eps of $3.46 for fiscal 2025.
Where can I see BMY's eps history?
The chart and table above show Bristol-Myers Squibb Company's eps by year and by quarter, including the growth rate.